WO2005018336A1 - Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13 - Google Patents

Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13 Download PDF

Info

Publication number
WO2005018336A1
WO2005018336A1 PCT/DK2004/000559 DK2004000559W WO2005018336A1 WO 2005018336 A1 WO2005018336 A1 WO 2005018336A1 DK 2004000559 W DK2004000559 W DK 2004000559W WO 2005018336 A1 WO2005018336 A1 WO 2005018336A1
Authority
WO
WIPO (PCT)
Prior art keywords
dough
amylase
exo
starch
glucogenic
Prior art date
Application number
PCT/DK2004/000559
Other languages
French (fr)
Inventor
Thomas Schäfer
Tina Spendler
Tina Hoff
Original Assignee
Novozymes A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes A/S filed Critical Novozymes A/S
Priority to CA2534935A priority Critical patent/CA2534935C/en
Priority to AU2004266059A priority patent/AU2004266059B2/en
Priority to US10/569,242 priority patent/US20080124427A1/en
Priority to EP04739045A priority patent/EP1657981A1/en
Publication of WO2005018336A1 publication Critical patent/WO2005018336A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/06Baking processes

Definitions

  • the present invention relates to a process for preparing a dough or an edible product made from dough, e.g. by baking or steaming. More particularly, it relates to such a process where the edible product has retarded staling.
  • EP 494233 discloses the addition to dough of a maltogenic exo-amylase in order to retard the staling of a baked product made from the dough.
  • the maltogenic exo-amylase is further described in EP 120693. The following describe the addition of various enzymes to dough: DE 19855352.
  • the invention provides a process for preparing a dough or an edible product made from dough, which process comprises adding a starch-degrading glucogenic exo-amylase of Family 13 to the dough.
  • the invention also provides a composition for use in this process.
  • Starch-degrading glucogenic exo-amylase of Family 13 The invention uses an enzyme which has the ability to degrade starch or amylopectin by releasing glucose as the major product. It may release glucose from the reducing end.
  • the starch-degrading glucogenic exo-amylase of Family 13 may also have the ability to hydrolyze maltooligosaccharides, e.g. with 3-7 glucose units.
  • the exo-amylase used in the invention belongs to Family 13 according to the classification based on amino acid sequence similarities, as described, e.g., in the following literature: • Henrissat B., A classification of glycosyl hydrolases based on amino-acid sequence similarities. Biochem. J.
  • the starch-degrading glucogenic exo-amylase of Family 13 may be obtained from a microbial source, such as bacteria, e.g. Thermotoga, particularly T.
  • exo-amylases are: • An exo-amylase from T. maritima described by M-H Lee et al., Biochem. Biophys. Res. Comm. 295 (2002) 818-825. It has optimum temperature and pH at 85°C and 6.5. It retains 80% of the activity at 90°C, but the residual activity is greatly reduced at 95°C. • An exo-amylase from T. neapolitana, prepared e.g.
  • Exo-amylases from T. maritima and T. neapolitana having the amino acid sequences shown in SEQ ID NO: 1 and 2, the two sequences having about 89 % amino acid identity.
  • An exo-amylase having at least 80 % identity to SEQ ID NO: 1 or 2, particularly at least 85 %, at least 90 % or at least 95 % identity.
  • the starch-degrading glucogenic exo-amylase of Family 13 may be chosen so as to have optimum pH of 4-7 and optimum temperature of 70-100°C, particularly 80-90°C.
  • the exo-amylase may be used at a dosage of 1-15 mg enzyme protein per kg flour, particularly 2- 10 mg/kg.
  • the dough may be leavened e.g. by adding chemical leavening agents or yeast, usually Saccharomyces cerevisiae (baker's yeast).
  • the dough generally comprises meal, flour or starch such as wheat meal, wheat flour, corn flour, corn starch, rye meal, rye flour, oat flour, oat meal, sorghum meal, sorghum flour, rice flour, potato meal, potato flour or potato starch.
  • the dough may be fresh, frozen or par-baked.
  • the dough may be a laminated dough.
  • the dough may also comprise other conventional dough ingredients, e.g.: proteins, such as milk powder and gluten; eggs (either whole eggs, egg yolks or egg whites); an oxidant such as ascorbic acid, potassium bromate, potassium iodate, azodicarbonamide (ADA) or ammonium persulfate; an amino acid such as L-cysteine; a sugar; a salt such as sodium chlo- ride, calcium acetate, sodium sulfate or calcium sulfate.
  • the dough may comprise fat (triglyc- eride) such as granulated fat or shortening.
  • the dough may further comprise an emulsifier such as mono- or diglycerides, diacetyl tartaric acid esters of mono- or diglycerides, sugar esters of fatty acids, polyglycerol esters of fatty acids, lactic acid esters of monoglycerides, acetic acid esters of monoglycerides, poly- oxyethylene stearates, or lysolecithin.
  • an emulsifier such as mono- or diglycerides, diacetyl tartaric acid esters of mono- or diglycerides, sugar esters of fatty acids, polyglycerol esters of fatty acids, lactic acid esters of monoglycerides, acetic acid esters of monoglycerides, poly- oxyethylene stearates, or lysolecithin.
  • the dough may be used to prepare an edible product, e.g. by leavening the dough and heating it, e.g. by baking or steaming.
  • the product may be of a soft or a crisp character, either of a white, light or dark type.
  • Examples are steamed or baked bread (in particular white, whole-meal or rye bread), typically in the form of loaves or rolls, French baguette-type bread, pita bread, tortillas, cakes, pancakes, biscuits, cookies, pie crusts, crisp bread, steamed bread, pizza and the like.
  • the starch-degrading glucogenic exo-amylase of Family 13 may optionally be used together with one or more additional enzymes.
  • the additional enzyme may be a lipolytic enzyme, particularly phospholipase, galac- toilipase and/or triacyl glycerol lipase activity, e.g. as described in WO 9953769. WO 0032758, WO 0200852 or WO 2002066622.
  • the additional enzyme may be a second amylase, a cyclodextrin glu- canotransferase, a protease or peptidase, in particular an exopeptidase, a transglutaminase, a lipase, a phospholipase, a cellulase, a hemicellulase, a glycosyltransferase, a branching enzyme (1 ,4- ⁇ -glucan branching enzyme) or an oxidoreductase.
  • the additional enzyme may be of mammalian, plant or microbial (bacterial, yeast or fungal) origin.
  • the second amylase may be from a fungus, bacterium or plant.
  • hemicellulase may be a pentosanase, e.g.
  • a xylanase which may be of microbial ori- gin, e.g. derived from a bacterium or fungus, such as a strain of Aspergillus, in particular of A. aculeatus, A. niger, A. awamori, or A. tubigensis, from a strain of Trichoderma, e.g. T. reesei, or from a strain of Humicola, e.g. H. insolens.
  • the protease may be from Bacillus, e.g. S. amyloliquefaciens.
  • the oxidoreductase may be a glucose oxidase, a hexose oxidase, a lipoxidase, a peroxidase, or a laccase.
  • the starch-degrading glucogenic exo-amylase of Family 13 may be provided as a dough and/or bread improving additive in the form of a granulate or agglomerated powder.
  • the dough and/or bread improving additive preferably may particularly have a narrow particle size distribution with more than 95 % (by weight) of the particles in the range from 25 to 500 ⁇ m.
  • Granulates and agglomerated powders may be prepared by conventional methods, e.g. by spraying the amylase onto a carrier in a fluid-bed granulator.
  • the carrier may consist of particulate cores having a suitable particle size.
  • the carrier may be soluble or insoluble, e.g. a salt (such as NaCI or sodium sulfate), a sugar (such as sucrose or lactose), a sugar alcohol (such as sorbitol), starch, rice, corn grits, or soy.
  • Alignment and identity For purposes of the present invention, alignments of amino acid sequences and calculation of identity scores were done using the software Align, a Needleman-Wunsch alignment (i.e. global alignment), useful for both protein and DNA alignments.
  • the default scoring matrices BLOSUM50 and the identity matrix are used for protein and DNA alignments respectively.
  • the penalty for the first residue in a gap is -12 for proteins and -16 for DNA, while the penalty for additional residues in a gap is -2 for proteins and -4 for DNA.
  • Align is from the FASTA package version v20u6 (W. R. Pearson and D. J. Lipman (1988), "Improved Tools for Biological Sequence Analysis", PNAS 85:2444-2448, and W. R. Pearson (1990) "Rapid and Sensitive Sequence Comparison with FASTP and FASTA", Methods in Enzymology, 183:63- 98).
  • the putative glucosidase gene was amplified by PCR using
  • oligonucleotide primers oth88 and oth89: SEQ ID NOS: 3 and 4
  • the 2 primers were designed from the known DNA sequence and a Ndel site and a Notl site were incorporated in the 5' end of oth ⁇ and oth89, respectively.
  • the DNA fragment was amplified with "Expand High Fidelity PCR System"(Boehringer Mannheim, Germany) using the following conditions: 94°C for 2 min followed by 30 cycles of; 94°C for 15 sec, 55°C for 30 sec, 68°C for 2 min, and ending with one cycle at 68°C for 10 min.
  • the amplified fragment was digested with Ndel and Notl and inserted in the expression vector pET44a (Novagen). The nucleotide sequence of the insert in the final clone was confirmed to be identical to the known sequence.
  • E.coli cells (BL21 Star (DEA3)pLysS (Novagen) containing the expression construct were grown in LB media + chloramphenicol (6ug/ml). After 2.5h expression was induced by adding IPTG to a final cone, of 0.5mM. The cells were harvested 4h after induction. The cells were resuspended in PBS - buffer, PH 7.3 (137mM NaCI, 2.7 mM KCI, 4.3 mM Na2HPO4
  • Example 1 Starch-degrading glucogenic exo-amylase of Family 13 from T. maritima (TMG) Doughs were made from 1 kg of flour using the European Straight dough procedure with addition of exo-amylase from 7. maritima. The dosage was 5 mg enzyme protein per kg flour. A control was made without addition of the exo-amylase. The doughs were baked into loaves of bread. The bread was wrapped and stored up to a week at ambient temperature. Firmness of the loaves was measured as described in WO 9953769. The results were as follows:
  • the results show that the glucogenic exo-amylase has anti-staling performance as it softens the crumb (reduced firmness) and slightly improves the elasticity after storage.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

The staling of an edible product made from dough can be retarded by adding a starch-degrading glucogenic exo-amylase of Family 13 to the dough, particularly an amylase from Thermotoga.

Description

PROCESS FOR PREPARING A DOUGH COMPRISING A STARCH-DEGRADING GLUCOGENIC EXO-AMYLASE OF FAMILY 13
FIELD OF THE INVENTION The present invention relates to a process for preparing a dough or an edible product made from dough, e.g. by baking or steaming. More particularly, it relates to such a process where the edible product has retarded staling.
BACKGROUND OF THE INVENTION EP 494233 discloses the addition to dough of a maltogenic exo-amylase in order to retard the staling of a baked product made from the dough. The maltogenic exo-amylase is further described in EP 120693. The following describe the addition of various enzymes to dough: DE 19855352. EP
412607. WO 9950399. US 6579546, US 4160848. EP 686348. US 2002028267. M-H Lee et al., Biochemical and Biophysical Research Communications, 295 (2002), 818-825 describes an amylolytic enzyme from Thermotoga maritima.
SUMMARY OF THE INVENTION The inventors have found that the staling of an edible product made by leavening and heating a dough can be retarded by adding a starch-degrading glucogenic exo-amylase of
Family 13 to the dough. Accordingly, the invention provides a process for preparing a dough or an edible product made from dough, which process comprises adding a starch-degrading glucogenic exo-amylase of Family 13 to the dough. The invention also provides a composition for use in this process.
DETAILED DESCRIPTION OF THE INVENTION
Starch-degrading glucogenic exo-amylase of Family 13 The invention uses an enzyme which has the ability to degrade starch or amylopectin by releasing glucose as the major product. It may release glucose from the reducing end. The starch-degrading glucogenic exo-amylase of Family 13 may also have the ability to hydrolyze maltooligosaccharides, e.g. with 3-7 glucose units. The exo-amylase used in the invention belongs to Family 13 according to the classification based on amino acid sequence similarities, as described, e.g., in the following literature: • Henrissat B., A classification of glycosyl hydrolases based on amino-acid sequence similarities. Biochem. J. 280:309-316(1991 ). • Henrissat B., Bairoch A. New families in the classification of glycosyl hydrolases based on amino- acid sequence similarities. Biochem. J. 293:781-788(1993). • Henrissat B., Bairoch A. Updating the sequence-based classification of glycosyl hydrolases. Biochem. J. 316:695-696(1996). • Davies G., Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure 3:853-859(1995). The starch-degrading glucogenic exo-amylase of Family 13 may be obtained from a microbial source, such as bacteria, e.g. Thermotoga, particularly T. ma tima or T. neapolitana, more particularly the strain MSB8. Some particular examples of exo-amylases are: • An exo-amylase from T. maritima described by M-H Lee et al., Biochem. Biophys. Res. Comm. 295 (2002) 818-825. It has optimum temperature and pH at 85°C and 6.5. It retains 80% of the activity at 90°C, but the residual activity is greatly reduced at 95°C. • An exo-amylase from T. neapolitana, prepared e.g. as described in the examples from the strain DSM 4359 (commercially available from DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg 1b, Braunschweig, Germany) • Exo-amylases from T. maritima and T. neapolitana having the amino acid sequences shown in SEQ ID NO: 1 and 2, the two sequences having about 89 % amino acid identity. • An exo-amylase having at least 80 % identity to SEQ ID NO: 1 or 2, particularly at least 85 %, at least 90 % or at least 95 % identity. The starch-degrading glucogenic exo-amylase of Family 13 may be chosen so as to have optimum pH of 4-7 and optimum temperature of 70-100°C, particularly 80-90°C. The exo-amylase may be used at a dosage of 1-15 mg enzyme protein per kg flour, particularly 2- 10 mg/kg.
Dough The dough may be leavened e.g. by adding chemical leavening agents or yeast, usually Saccharomyces cerevisiae (baker's yeast). The dough generally comprises meal, flour or starch such as wheat meal, wheat flour, corn flour, corn starch, rye meal, rye flour, oat flour, oat meal, sorghum meal, sorghum flour, rice flour, potato meal, potato flour or potato starch. The dough may be fresh, frozen or par-baked. The dough may be a laminated dough. The dough may also comprise other conventional dough ingredients, e.g.: proteins, such as milk powder and gluten; eggs (either whole eggs, egg yolks or egg whites); an oxidant such as ascorbic acid, potassium bromate, potassium iodate, azodicarbonamide (ADA) or ammonium persulfate; an amino acid such as L-cysteine; a sugar; a salt such as sodium chlo- ride, calcium acetate, sodium sulfate or calcium sulfate. The dough may comprise fat (triglyc- eride) such as granulated fat or shortening. The dough may further comprise an emulsifier such as mono- or diglycerides, diacetyl tartaric acid esters of mono- or diglycerides, sugar esters of fatty acids, polyglycerol esters of fatty acids, lactic acid esters of monoglycerides, acetic acid esters of monoglycerides, poly- oxyethylene stearates, or lysolecithin.
Edible product The dough may be used to prepare an edible product, e.g. by leavening the dough and heating it, e.g. by baking or steaming. The product may be of a soft or a crisp character, either of a white, light or dark type. Examples are steamed or baked bread (in particular white, whole-meal or rye bread), typically in the form of loaves or rolls, French baguette-type bread, pita bread, tortillas, cakes, pancakes, biscuits, cookies, pie crusts, crisp bread, steamed bread, pizza and the like.
Optional additional enzyme The starch-degrading glucogenic exo-amylase of Family 13 may optionally be used together with one or more additional enzymes. The additional enzyme may be a lipolytic enzyme, particularly phospholipase, galac- toilipase and/or triacyl glycerol lipase activity, e.g. as described in WO 9953769. WO 0032758, WO 0200852 or WO 2002066622. Further, the additional enzyme may be a second amylase, a cyclodextrin glu- canotransferase, a protease or peptidase, in particular an exopeptidase, a transglutaminase, a lipase, a phospholipase, a cellulase, a hemicellulase, a glycosyltransferase, a branching enzyme (1 ,4-α-glucan branching enzyme) or an oxidoreductase. The additional enzyme may be of mammalian, plant or microbial (bacterial, yeast or fungal) origin. The second amylase may be from a fungus, bacterium or plant. It may be a maltogenic alpha-amylase (EC 3.2.1.133), e.g. from B. stearothermophilus, an alpha-amylase, e.g. from Bacillus, particularly B. licheniformis or B. amyloliquefaciens, a beta-amylase, e.g. from plant (e.g. soy bean) or from microbial sources (e.g. Bacillus), a glucoamylase, e.g. from A. niger, or a fungal alpha-amylase, e.g. from A. oryzae. The hemicellulase may be a pentosanase, e.g. a xylanase which may be of microbial ori- gin, e.g. derived from a bacterium or fungus, such as a strain of Aspergillus, in particular of A. aculeatus, A. niger, A. awamori, or A. tubigensis, from a strain of Trichoderma, e.g. T. reesei, or from a strain of Humicola, e.g. H. insolens. The protease may be from Bacillus, e.g. S. amyloliquefaciens. The oxidoreductase may be a glucose oxidase, a hexose oxidase, a lipoxidase, a peroxidase, or a laccase.
Dough and/or bread-improving additive The starch-degrading glucogenic exo-amylase of Family 13 may be provided as a dough and/or bread improving additive in the form of a granulate or agglomerated powder. The dough and/or bread improving additive preferably may particularly have a narrow particle size distribution with more than 95 % (by weight) of the particles in the range from 25 to 500 μm. Granulates and agglomerated powders may be prepared by conventional methods, e.g. by spraying the amylase onto a carrier in a fluid-bed granulator. The carrier may consist of particulate cores having a suitable particle size. The carrier may be soluble or insoluble, e.g. a salt (such as NaCI or sodium sulfate), a sugar (such as sucrose or lactose), a sugar alcohol (such as sorbitol), starch, rice, corn grits, or soy.
Alignment and identity For purposes of the present invention, alignments of amino acid sequences and calculation of identity scores were done using the software Align, a Needleman-Wunsch alignment (i.e. global alignment), useful for both protein and DNA alignments. The default scoring matrices BLOSUM50 and the identity matrix are used for protein and DNA alignments respectively. The penalty for the first residue in a gap is -12 for proteins and -16 for DNA, while the penalty for additional residues in a gap is -2 for proteins and -4 for DNA. Align is from the FASTA package version v20u6 (W. R. Pearson and D. J. Lipman (1988), "Improved Tools for Biological Sequence Analysis", PNAS 85:2444-2448, and W. R. Pearson (1990) "Rapid and Sensitive Sequence Comparison with FASTP and FASTA", Methods in Enzymology, 183:63- 98).
EXAMPLES
Preparation example: Cloning of Thermotoga neapolitana TMG homolog SWALL: 086959, EMBL AJ009832
Cloning Chromosomal DNA of T. neapolitana strain DSM 4359 was isolated by QIAmp Tissue
Kit (Qiagen, Hilden, Germany). The putative glucosidase gene was amplified by PCR using
T.neapolitana genomic DNA as template and two oligonucleotide primers (oth88 and oth89: SEQ ID NOS: 3 and 4). The 2 primers were designed from the known DNA sequence and a Ndel site and a Notl site were incorporated in the 5' end of othδδ and oth89, respectively. The DNA fragment was amplified with "Expand High Fidelity PCR System"(Boehringer Mannheim, Germany) using the following conditions: 94°C for 2 min followed by 30 cycles of; 94°C for 15 sec, 55°C for 30 sec, 68°C for 2 min, and ending with one cycle at 68°C for 10 min. The amplified fragment was digested with Ndel and Notl and inserted in the expression vector pET44a (Novagen). The nucleotide sequence of the insert in the final clone was confirmed to be identical to the known sequence.
Expression and purification of the recombinant Thermotoaa neapolitana enzyme: E.coli cells (BL21 Star (DEA3)pLysS (Novagen) containing the expression construct were grown in LB media + chloramphenicol (6ug/ml). After 2.5h expression was induced by adding IPTG to a final cone, of 0.5mM. The cells were harvested 4h after induction. The cells were resuspended in PBS - buffer, PH 7.3 (137mM NaCI, 2.7 mM KCI, 4.3 mM Na2HPO4
*7H2O, 1.4 mM KH2PO4) and sonicated . Cell debris was spun down and the supernatant containing the enzyme was incubated at 80°C for 15 min, centrifuged at 20.000rpm for 30 min at 4°C. The supernatant contained the enzyme.
Example 1: Starch-degrading glucogenic exo-amylase of Family 13 from T. maritima (TMG) Doughs were made from 1 kg of flour using the European Straight dough procedure with addition of exo-amylase from 7. maritima. The dosage was 5 mg enzyme protein per kg flour. A control was made without addition of the exo-amylase. The doughs were baked into loaves of bread. The bread was wrapped and stored up to a week at ambient temperature. Firmness of the loaves was measured as described in WO 9953769. The results were as follows:
Figure imgf000006_0001
Elasticity of the loaves was measured as described in US 6162628. The results were as follows:
Figure imgf000006_0002
Figure imgf000007_0001
The results show that the glucogenic exo-amylase has anti-staling performance as it softens the crumb (reduced firmness) and slightly improves the elasticity after storage.

Claims

1. A process for preparing a dough or an edible product made from dough, which process comprises adding a starch-degrading glucogenic exo-amylase of Family 13 to the dough.
2. The process of claim 1 wherein the edible product is made by leavening and heating the dough.
3. The process of claim 2 wherein the heating comprises baking or steaming.
4. The process of any of claims 1-3 wherein the exo-amylase is derivable from a strain of Thermotoga, particularly 7. maritima or 7. neapolitana, more particularly strain MSB8,
5. The process of any of claims 1-4 wherein the exo-amylase has an amino acid se- quence which is at least 80 % identical to SEQ ID NO: 1 or 2.
6. A flour composition which comprises flour and a starch-degrading glucogenic exo- amylase of Family 13.
7. The composition of claim 6 which is a dough.
8. A dough- or bread-improving additive in the form of a granulate or agglomerated pow- der comprising a starch-degrading glucogenic exo-amylase of Family 13.
9. The additive of claim 8 wherein more than 95 % (by weight) has a particle size between 25 and 500 μm.
PCT/DK2004/000559 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13 WO2005018336A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA2534935A CA2534935C (en) 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13
AU2004266059A AU2004266059B2 (en) 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of Family 13
US10/569,242 US20080124427A1 (en) 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amy-lase of family 13
EP04739045A EP1657981A1 (en) 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301202 2003-08-22
DKPA200301202 2003-08-22

Publications (1)

Publication Number Publication Date
WO2005018336A1 true WO2005018336A1 (en) 2005-03-03

Family

ID=34203113

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2004/000559 WO2005018336A1 (en) 2003-08-22 2004-08-23 Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13

Country Status (5)

Country Link
US (1) US20080124427A1 (en)
EP (1) EP1657981A1 (en)
AU (1) AU2004266059B2 (en)
CA (1) CA2534935C (en)
WO (1) WO2005018336A1 (en)

Cited By (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194117A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194032A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2015089447A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of the bacillus gibsonii-clade
WO2015089441A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of bacillus species
WO2015095358A1 (en) 2013-12-18 2015-06-25 E. I. Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
WO2015123323A1 (en) 2014-02-14 2015-08-20 E. I. Du Pont De Nemours And Company Poly-alpha-1,3-1,6-glucans for viscosity modification
WO2015138283A1 (en) 2014-03-11 2015-09-17 E. I. Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan as detergent builder
WO2015195960A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015195777A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2016061438A1 (en) 2014-10-17 2016-04-21 Danisco Us Inc. Serine proteases of bacillus species
WO2016069569A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069548A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
WO2016106011A1 (en) 2014-12-23 2016-06-30 E. I. Du Pont De Nemours And Company Enzymatically produced cellulose
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
WO2016201044A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Osmotic burst encapsulates
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
WO2016205755A1 (en) 2015-06-17 2016-12-22 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2017079751A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus sp. mannanases
WO2017079756A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus and bacillus spp. mannanases
WO2017083228A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017083226A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017083229A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017106676A1 (en) 2015-12-18 2017-06-22 Danisco Us Inc Polypeptides with endoglucanase activity and uses thereof
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017210295A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
WO2017219011A1 (en) 2016-06-17 2017-12-21 Danisco Us Inc Protease variants and uses thereof
WO2018085524A2 (en) 2016-11-07 2018-05-11 Danisco Us Inc Laundry detergent composition
WO2018118917A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2018183662A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Delayed release enzyme formulations for bleach-containing detergents
WO2019006077A1 (en) 2017-06-30 2019-01-03 Danisco Us Inc Low-agglomeration, enzyme-containing particles
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
WO2019125683A1 (en) 2017-12-21 2019-06-27 Danisco Us Inc Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant
WO2019156670A1 (en) 2018-02-08 2019-08-15 Danisco Us Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
EP3587569A1 (en) 2014-03-21 2020-01-01 Danisco US Inc. Serine proteases of bacillus species
WO2020047215A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Enzyme-containing granules
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
WO2020112599A1 (en) 2018-11-28 2020-06-04 Danisco Us Inc Subtilisin variants having improved stability
WO2020242858A1 (en) 2019-05-24 2020-12-03 Danisco Us Inc Subtilisin variants and methods of use
WO2020247582A1 (en) 2019-06-06 2020-12-10 Danisco Us Inc Methods and compositions for cleaning
EP3872174A1 (en) 2015-05-13 2021-09-01 Danisco US Inc. Aprl-clade protease variants and uses thereof
WO2022047149A1 (en) 2020-08-27 2022-03-03 Danisco Us Inc Enzymes and enzyme compositions for cleaning
WO2022165107A1 (en) 2021-01-29 2022-08-04 Danisco Us Inc Compositions for cleaning and methods related thereto
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
WO2023034486A2 (en) 2021-09-03 2023-03-09 Danisco Us Inc. Laundry compositions for cleaning
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
EP4163305A1 (en) 2013-12-16 2023-04-12 Nutrition & Biosciences USA 4, Inc. Use of poly alpha-1,3-glucan ethers as viscosity modifiers
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2023250301A1 (en) 2022-06-21 2023-12-28 Danisco Us Inc. Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
US11920170B2 (en) 2015-12-09 2024-03-05 Danisco Us Inc. Alpha-amylase combinatorial variants
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666457B1 (en) 2008-08-19 2010-02-23 Delavau Llc Dry mixes comprising glycerine
AR087158A1 (en) 2011-06-20 2014-02-26 Gen Biscuit HEALTHY COAT MASITA

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160848A (en) * 1977-04-18 1979-07-10 Pennwalt Corporation Antistaling agent for bakery products
EP0412607A1 (en) * 1989-08-10 1991-02-13 Gist-Brocades N.V. Retarding the firming of bread crumb during storage
EP0686348A1 (en) * 1994-05-30 1995-12-13 Amano Pharmaceutical Co., Ltd. Bread quality-improving composition and bread producing process using the same
WO1999050399A2 (en) * 1998-04-01 1999-10-07 Danisco A/S Non-maltogenic exoamylases and their use in retarding retrogradation of starch
DE19855352A1 (en) * 1998-12-01 2000-06-08 Verein Zur Foerderung Des Tech Breadmaking additive for preparation of doughs with improved consistency and gas-holding capability comprises mixture of glucose-oxidase/catalase, exo-amylase and endo-amylase enzymes
US20020028267A1 (en) * 1996-05-13 2002-03-07 Hubert A. Herrmann Enzyme granulate for use in food technology
US6579546B1 (en) * 2001-01-03 2003-06-17 Brechet & Richter Company Method of making microwavable yeast-leavended bakery product containing dough additive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933141B1 (en) * 1999-10-01 2005-08-23 Novozymes A/S Enzyme granulate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160848A (en) * 1977-04-18 1979-07-10 Pennwalt Corporation Antistaling agent for bakery products
EP0412607A1 (en) * 1989-08-10 1991-02-13 Gist-Brocades N.V. Retarding the firming of bread crumb during storage
EP0686348A1 (en) * 1994-05-30 1995-12-13 Amano Pharmaceutical Co., Ltd. Bread quality-improving composition and bread producing process using the same
US20020028267A1 (en) * 1996-05-13 2002-03-07 Hubert A. Herrmann Enzyme granulate for use in food technology
WO1999050399A2 (en) * 1998-04-01 1999-10-07 Danisco A/S Non-maltogenic exoamylases and their use in retarding retrogradation of starch
DE19855352A1 (en) * 1998-12-01 2000-06-08 Verein Zur Foerderung Des Tech Breadmaking additive for preparation of doughs with improved consistency and gas-holding capability comprises mixture of glucose-oxidase/catalase, exo-amylase and endo-amylase enzymes
US6579546B1 (en) * 2001-01-03 2003-06-17 Brechet & Richter Company Method of making microwavable yeast-leavended bakery product containing dough additive

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BEREZINA, ZVERLOV, LUNINA, CHEKANOVSKAYA,DUBININA, LIEBL AND VELIKODVORSKAYA: "Gene and properties of thermostable 4-alpha-glucanotransferase of Thermotoga neapolitana", MOLECULAR BIOLOGY, vol. 33, no. 5, 1999, pages 906 - 911, XP008027680 *
LIEBL, STEMPLINGER AND RUILE: "Properties and Gene structure of the Thermotoga maritima, alpha-amylase AmyA", JOURNAL OF BACTERIOLOGY, vol. 179, no. 3, 1997, pages 941 - 948, XP002270827 *
MYONG-HEE LEE, YOUNG-WAN KIM, TAE-JIP KIM, CHEON-SEOK PARK: "A novel amylolytic enzyme from Thermotoga maritima, resembling cyclodextrinase and alpha-glucosidas, that liberates glucose from the reducing end of the substrates", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 295, 2002, pages 818 - 825, XP002270421 *
VAN DER MAAREL, VAN DER VEEN, UITDEHAAG, LEEMHUIS, DIJKHUIZEN: "Properties and applications of starch-converting enzymes of the alpha-amylase family", JOURNAL OF BIOTECHNOLOGY, vol. 94, no. 2, 2002, pages 137 - 155, XP002270826 *

Cited By (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3636662A1 (en) 2013-05-29 2020-04-15 Danisco US Inc. Novel metalloproteases
WO2014194117A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194032A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP4159854A1 (en) 2013-05-29 2023-04-05 Danisco US Inc Novel metalloproteases
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP3882346A1 (en) 2013-05-29 2021-09-22 Danisco US Inc. Novel metalloproteases
EP3260538A1 (en) 2013-05-29 2017-12-27 Danisco US Inc. Novel metalloproteases
WO2015089441A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of bacillus species
EP3514230A1 (en) 2013-12-13 2019-07-24 Danisco US Inc. Serine proteases of bacillus species
EP3553173A1 (en) 2013-12-13 2019-10-16 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
EP3910057A1 (en) 2013-12-13 2021-11-17 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
WO2015089447A1 (en) 2013-12-13 2015-06-18 Danisco Us Inc. Serine proteases of the bacillus gibsonii-clade
EP4163305A1 (en) 2013-12-16 2023-04-12 Nutrition & Biosciences USA 4, Inc. Use of poly alpha-1,3-glucan ethers as viscosity modifiers
EP3789407A1 (en) 2013-12-18 2021-03-10 Nutrition & Biosciences USA 4, Inc. Cationic poly alpha-1,3-glucan ethers
WO2015095358A1 (en) 2013-12-18 2015-06-25 E. I. Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
WO2015123323A1 (en) 2014-02-14 2015-08-20 E. I. Du Pont De Nemours And Company Poly-alpha-1,3-1,6-glucans for viscosity modification
WO2015138283A1 (en) 2014-03-11 2015-09-17 E. I. Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan as detergent builder
EP3587569A1 (en) 2014-03-21 2020-01-01 Danisco US Inc. Serine proteases of bacillus species
EP4155398A1 (en) 2014-03-21 2023-03-29 Danisco US Inc. Serine proteases of bacillus species
WO2015195960A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015195777A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
EP3919599A1 (en) 2014-06-19 2021-12-08 Nutrition & Biosciences USA 4, Inc. Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2016061438A1 (en) 2014-10-17 2016-04-21 Danisco Us Inc. Serine proteases of bacillus species
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
EP3550017A1 (en) 2014-10-27 2019-10-09 Danisco US Inc. Serine proteases
EP4403631A2 (en) 2014-10-27 2024-07-24 Danisco US Inc. Serine proteases
WO2016069569A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069548A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016106011A1 (en) 2014-12-23 2016-06-30 E. I. Du Pont De Nemours And Company Enzymatically produced cellulose
EP4219704A2 (en) 2015-05-13 2023-08-02 Danisco US Inc Aprl-clade protease variants and uses thereof
EP3872174A1 (en) 2015-05-13 2021-09-01 Danisco US Inc. Aprl-clade protease variants and uses thereof
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
WO2016201044A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Osmotic burst encapsulates
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
WO2016205755A1 (en) 2015-06-17 2016-12-22 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
EP4234693A2 (en) 2015-06-17 2023-08-30 Danisco US Inc Bacillus gibsonii-clade serine proteases
WO2017079751A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus sp. mannanases
WO2017079756A1 (en) 2015-11-05 2017-05-11 Danisco Us Inc Paenibacillus and bacillus spp. mannanases
EP4141113A1 (en) 2015-11-05 2023-03-01 Danisco US Inc Paenibacillus sp. mannanases
WO2017083228A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017083229A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
US10876074B2 (en) 2015-11-13 2020-12-29 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
US10844324B2 (en) 2015-11-13 2020-11-24 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
US10822574B2 (en) 2015-11-13 2020-11-03 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
WO2017083226A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
US11920170B2 (en) 2015-12-09 2024-03-05 Danisco Us Inc. Alpha-amylase combinatorial variants
WO2017106676A1 (en) 2015-12-18 2017-06-22 Danisco Us Inc Polypeptides with endoglucanase activity and uses thereof
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
EP3845642A1 (en) 2016-05-05 2021-07-07 Danisco US Inc. Protease variants and uses thereof
WO2017210295A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
EP4151726A1 (en) 2016-06-17 2023-03-22 Danisco US Inc Protease variants and uses thereof
WO2017219011A1 (en) 2016-06-17 2017-12-21 Danisco Us Inc Protease variants and uses thereof
WO2018085524A2 (en) 2016-11-07 2018-05-11 Danisco Us Inc Laundry detergent composition
WO2018112123A1 (en) 2016-12-15 2018-06-21 Danisco Us Inc. Polypeptides with endoglucanase activity and uses thereof
EP4212622A2 (en) 2016-12-21 2023-07-19 Danisco US Inc. Bacillus gibsonii-clade serine proteases
WO2018118917A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2018183662A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Delayed release enzyme formulations for bleach-containing detergents
WO2019006077A1 (en) 2017-06-30 2019-01-03 Danisco Us Inc Low-agglomeration, enzyme-containing particles
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
WO2019125683A1 (en) 2017-12-21 2019-06-27 Danisco Us Inc Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant
WO2019156670A1 (en) 2018-02-08 2019-08-15 Danisco Us Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2020047215A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Enzyme-containing granules
WO2020068486A1 (en) 2018-09-27 2020-04-02 Danisco Us Inc Compositions for medical instrument cleaning
WO2020112599A1 (en) 2018-11-28 2020-06-04 Danisco Us Inc Subtilisin variants having improved stability
WO2020242858A1 (en) 2019-05-24 2020-12-03 Danisco Us Inc Subtilisin variants and methods of use
WO2020247582A1 (en) 2019-06-06 2020-12-10 Danisco Us Inc Methods and compositions for cleaning
WO2022047149A1 (en) 2020-08-27 2022-03-03 Danisco Us Inc Enzymes and enzyme compositions for cleaning
WO2022165107A1 (en) 2021-01-29 2022-08-04 Danisco Us Inc Compositions for cleaning and methods related thereto
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
WO2023034486A2 (en) 2021-09-03 2023-03-09 Danisco Us Inc. Laundry compositions for cleaning
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2023250301A1 (en) 2022-06-21 2023-12-28 Danisco Us Inc. Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use

Also Published As

Publication number Publication date
EP1657981A1 (en) 2006-05-24
AU2004266059A1 (en) 2005-03-03
US20080124427A1 (en) 2008-05-29
CA2534935A1 (en) 2005-03-03
AU2004266059B2 (en) 2010-04-01
CA2534935C (en) 2012-07-17

Similar Documents

Publication Publication Date Title
AU2004266059B2 (en) Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of Family 13
CA2326412C (en) Preparation of dough and baked products
US6365204B1 (en) Preparation of dough and baked products
US20090226564A1 (en) Bacterial alpha-amylase variants
EP2620496B1 (en) Alpha-amylase
EP2981170A1 (en) Method of producing a baked product with alpha-amylase, lipase and phospholipase
US10327449B2 (en) Alpha-amylase variants
US20110091601A1 (en) Preparation of An Edible Product From Dough
US20010055635A1 (en) Preparation of dough and baked products
EP1326497B1 (en) Preparation of baked product from dough
US9808018B2 (en) Alpha-amylase variants
WO2024118096A1 (en) Baking at low-ph with thermostable glucoamylase variants
CA2362913A1 (en) Methods for using lactonohydrolases in baking

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2534935

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004266059

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004739045

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10569242

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2004266059

Country of ref document: AU

Date of ref document: 20040823

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004266059

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004739045

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10569242

Country of ref document: US